Ignite Creation Date:
2025-12-25 @ 1:08 AM
Ignite Modification Date:
2026-02-27 @ 8:27 AM
Study NCT ID:
NCT03404193
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-05
First Post:
2018-01-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome
Sponsor:
Organization: